Advertisement
AXON vs SEER
Which Stock Would AI Choose? Axon Enterprise (AXON) vs. Seer (SEER) Stock Comparison
Key Takeaways
- Tickeron AI Verdict: AXON is the favored ticker, reflecting stronger trend consistency, revenue growth, and market positioning relative to SEER.
- AXON is a large-cap public safety technology leader growing revenue roughly 30% annually, while SEER is a micro-cap life sciences company with modest revenue and ongoing net losses.
- SEER trades below its net cash position and faces activist investor pressure, whereas AXON benefits from recurring software revenue and an expanding hardware ecosystem.
- Relative performance diverges sharply: AXON offers a liquid, established growth profile, while SEER carries higher volatility and concentrated governance risk.
- For more details on either name, explore AXON Major News and AXON Today's Price Move, or SEER Major News and SEER Today's Price Move.
- To see how automated strategies are positioning across the market, explore Trending AI Robots.
Introduction
This stock comparison places two very different Nasdaq-listed companies side by side: AXON (Axon Enterprise, Inc.), a scaled public safety technology firm, and SEER (Seer, Inc.), a small-cap life sciences company focused on proteomics. They operate in unrelated industries, yet both hold interest for traders evaluating relative performance and market positioning. Growth-oriented investors may weigh AXON's established recurring-revenue model against SEER's deep-value, cash-rich profile. The contrast in scale, profitability, and momentum makes this a useful case study in how AI-driven analysis approaches two stocks with fundamentally different risk-reward profiles.
AXON Overview and Recent Performance
AXON develops integrated hardware and cloud software for law enforcement and first responders, including TASER energy weapons, body cameras, digital evidence management, and counter-drone systems. In recent quarters it has grown revenue at a roughly 30% annual pace, supported by strong demand for its TASER 10, Axon Body 4, and expanding software and services segment, alongside rising annual recurring revenue from its AI-powered offerings.
Recent market activity has been uneven. A quarterly report in late 2025 showed revenue growth but an earnings shortfall, with tariff-related cost pressure and elevated stock-based compensation weighing on margins and triggering a sharp sell-off. A subsequent quarter delivered stronger top-line results and an earnings beat, though margin compression from tariffs and product mix remains a watch item. Analysts maintain a broadly constructive view, and the company has reiterated multi-year revenue and profitability targets while expanding into enterprise and international markets.
SEER Overview and Recent Performance
SEER is a life sciences company commercializing the Proteograph Product Suite, a platform using engineered nanoparticles for deep, unbiased proteomic analysis. Its model pairs consumables, automation instruments, and software, with revenue derived primarily from instrument placements and growing consumable kit volume. Full-year revenue is in the mid-teens of millions of dollars, and the company continues to report significant net losses.
Recent weeks have been eventful. The company announced an ITC (International Trade Commission) patent enforcement victory against a competitor, and its board concluded a strategic review, rejecting acquisition proposals to remain an independent public company. Activist investors holding a meaningful stake have issued open letters criticizing operating results, cash burn, and governance, and have questioned the decision to stay public. SEER holds a substantial cash balance relative to its market capitalization, but faces funding-environment uncertainty and elongated sales cycles.
Trending AI Robots
Tickeron's Trending AI Robots page highlights a curated selection of automated trading strategies drawn from hundreds of AI trading bots that collectively trade thousands of different tickers. Because each bot operates with its own style, timeframe, strategy, and performance record, only those best suited to prevailing market conditions are featured in this section. The curated list surfaces bots with notable statistical profiles, giving traders a practical starting point for evaluating systematic approaches across both large-cap names like AXON and speculative small caps like SEER. Investors seeking a data-driven complement to manual analysis can explore Trending AI Robots to review current selections and their performance metrics.
Head-to-Head Comparison
The two companies differ fundamentally across every relevant dimension. AXON is a profitable-on-an-adjusted-basis, multi-billion-dollar operator with a diversified hardware-plus-software revenue mix and a recurring subscription base that supports revenue visibility. Its growth drivers include international expansion, enterprise adoption, and counter-drone demand, while its key risks center on margin compression from tariffs, product mix, and valuation sensitivity.
SEER, by contrast, is an early-commercial-stage company whose market capitalization sits below its cash holdings. Its growth hinges on converting instrument placements into recurring consumable pull-through in a funding-constrained research environment. Governance disputes and activist scrutiny add idiosyncratic risk, though the cash cushion and patent position provide some downside support. In terms of sector exposure, AXON is tied to public safety and defense-adjacent spending, while SEER is exposed to life sciences research budgets and NIH (National Institutes of Health) funding dynamics.
Tickeron AI Verdict
Based on observable factors such as trend consistency, revenue momentum, liquidity, and relative stability, Tickeron's AI would currently favor AXON. The company's recurring revenue growth, broader institutional following, and more consistent demand narrative offer a comparatively clearer directional signal than SEER's earlier-stage, catalyst-dependent profile. While SEER presents a value-oriented setup supported by net cash, its governance overhang and uncertain funding backdrop introduce volatility that reduces its attractiveness as a momentum-consistent candidate. This assessment reflects a probabilistic reading of current positioning rather than a definitive forecast.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a Hold and SEER is a Hold.
AXON's RSI Oscillator descends into oversold zone
The RSI Indicator for AXON moved into overbought territory on November 06, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +1.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXON advanced for three days, in 273 of 370 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
AXON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXON as a result. In 55 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 72%.
The Moving Average Convergence Divergence Histogram (MACD) for AXON turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 32 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for AXON entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. AXON’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 80 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is 81 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.920) is normal, around the industry mean (5.050). AXON has a moderately high P/E Ratio (126.721) as compared to the industry average of (17.247). Projected Growth (PEG Ratio) (1.949) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (12.034) is also within normal values, averaging (18.367).
Momentum Indicator for SEER turns negative, indicating new downward trend
SEER saw its Momentum Indicator move below the 0 level on October 13, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned negative. In 72 of the 81 cases, the stock moved further down in the following days. The odds of a decline are at 89%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for SEER turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 44 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.
SEER moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for SEER crossed bearishly below the 50-day moving average on October 26, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SEER declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for SEER entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +3.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where SEER advanced for three days, in 162 of 225 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
SEER may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.400) is normal, around the industry mean (3.498). P/E Ratio (-1.336) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (7.800) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. SEER’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SEER’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
AXON | SEER | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | 34 Fair valued | |
PROFIT vs RISK RATING 1..100 | 80 | 100 | |
SMR RATING 1..100 | 81 | 96 | |
PRICE GROWTH RATING 1..100 | 65 | 77 | |
P/E GROWTH RATING 1..100 | 81 | 22 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SEER's Valuation (34) in the null industry is somewhat better than the same rating for AXON (90) in the Biotechnology industry. This means that SEER’s stock grew somewhat faster than AXON’s over the last 12 months.
AXON's Profit vs Risk Rating (80) in the Biotechnology industry is in the same range as SEER (100) in the null industry. This means that AXON’s stock grew similarly to SEER’s over the last 12 months.
AXON's SMR Rating (81) in the Biotechnology industry is in the same range as SEER (96) in the null industry. This means that AXON’s stock grew similarly to SEER’s over the last 12 months.
AXON's Price Growth Rating (65) in the Biotechnology industry is in the same range as SEER (77) in the null industry. This means that AXON’s stock grew similarly to SEER’s over the last 12 months.
SEER's P/E Growth Rating (22) in the null industry is somewhat better than the same rating for AXON (81) in the Biotechnology industry. This means that SEER’s stock grew somewhat faster than AXON’s over the last 12 months.
| AXON | SEER | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 86% | 4 days ago 69% |
| Stochastic ODDS (%) | 4 days ago 82% | 4 days ago 73% |
| Momentum ODDS (%) | 4 days ago 72% | 4 days ago 89% |
| MACD ODDS (%) | 4 days ago 84% | 4 days ago 86% |
| TrendWeek ODDS (%) | 4 days ago 69% | 4 days ago 84% |
| TrendMonth ODDS (%) | 4 days ago 71% | 4 days ago 83% |
| Advances ODDS (%) | 14 days ago 74% | 13 days ago 72% |
| Declines ODDS (%) | 4 days ago 70% | 5 days ago 84% |
| BollingerBands ODDS (%) | 4 days ago 79% | 4 days ago 76% |
| Aroon ODDS (%) | 4 days ago 80% | 4 days ago 80% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AXON’s FA Score shows that 0 FA rating(s) are green while SEER’s FA Score has 1 green FA rating(s).
- AXON’s FA Score: 0 green, 5 red.
- SEER’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AXON’s TA Score shows that 4 TA indicator(s) are bullish while SEER’s TA Score has 4 bullish TA indicator(s).
- AXON’s TA Score: 4 bullish, 4 bearish.
- SEER’s TA Score: 4 bullish, 6 bearish.
Price Growth
AXON (@Aerospace & Defense) experienced а -26.83% price change this week, while SEER (@Biotechnology) price change was -2.98% for the same time period.
The average weekly price growth across all stocks in the @Aerospace & Defense industry was +2.89%. For the same industry, the average monthly price growth was -3.78%, and the average quarterly price growth was -16.05%.
The average weekly price growth across all stocks in the @Biotechnology industry was +2.97%. For the same industry, the average monthly price growth was -8.33%, and the average quarterly price growth was +85.08%.
Reported Earning Dates
AXON is expected to report earnings on Mar 02, 2027.
SEER is expected to report earnings on Nov 10, 2026.
Industries' Descriptions
@Aerospace & Defense (+2.89% weekly)Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.
@Biotechnology (+2.97% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
AXON and
Correlation & Price change
A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.
| Ticker / NAME | Correlation To AXON | 1D Price Change % | ||
|---|---|---|---|---|
| AXON | 100% | -18.18% | ||
| TECH - AXON | 61% Loosely correlated | +0.17% | ||
| VCYT - AXON | 58% Loosely correlated | +0.67% | ||
| BEAM - AXON | 57% Loosely correlated | +2.09% | ||
| SEER - AXON | 56% Loosely correlated | N/A | ||
| ADPT - AXON | 56% Loosely correlated | +4.29% | ||
More | ||||
SEER and
Correlation & Price change
A.I.dvisor indicates that over the last year, SEER has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SEER jumps, then AXON could also see price increases.
| Ticker / NAME | Correlation To SEER | 1D Price Change % | ||
|---|---|---|---|---|
| SEER | 100% | N/A | ||
| AXON - SEER | 56% Loosely correlated | -18.18% | ||
| ARRY - SEER | 47% Loosely correlated | +10.47% | ||
| RNA - SEER | 36% Loosely correlated | +0.24% | ||
| VCYT - SEER | 35% Loosely correlated | +0.67% | ||
| DNA - SEER | 34% Loosely correlated | +13.35% | ||
More | ||||